MiniMedTM780G Insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy
- 31 May 2021
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Medical Devices
- Vol. 18 (6) , 499-504
Abstract
Introduction: Despite significant advances in diabetes care over the last three decades, the majority of people living with T1D are not meeting established metabolic goals. Automated insulin delivery can help achieve these metabolic goals (HbA1c and TIR). Areas covered: This review examines the new features and available data regarding safety and efficacy of the MiniMed™ 780 G, a second-generation advanced hybrid closed-loop system. Reported outcomes include time in, above and below range, HbA1c, diabetic ketoacidosis and severe hypoglycemia. Expert opinion: The initial pivotal trials of the MiniMed™ 780 G have demonstrated promising clinical and safety outcomes. Real-world data and longer-term studies are still needed. The success of AID devices moving forward hinges on their ease of use and ability to reduce and relieve the burden of living with T1D.Keywords
This publication has 22 references indexed in Scilit:
- Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial LaunchDiabetes Technology & Therapeutics, 2018
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 DiabetesJAMA, 2016
- Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose ManagementDiabetes Technology & Therapeutics, 2016
- Threshold-Based Insulin-Pump Interruption for Reduction of HypoglycemiaNew England Journal of Medicine, 2013
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesNew England Journal of Medicine, 2010
- Juvenile Diabetes Research Foundation Artificial Pancreas Consortium UpdateJournal of Diabetes Science and Technology, 2009
- Insulin pumps: from inception to the present and toward the futureJournal of Clinical Pharmacy and Therapeutics, 2009
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Continuous Subcutaneous Insulin InfusionArchives of internal medicine (1960), 2001
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993